Statins cut oesophageal cancer risk

A history of statin use significantly reduces the risk of developing any of the main histological subtypes of oesophageal cancer, a large UK study has revealed.

The population-based study identified all individuals in the UK General Practice Database with oesophageal cancer diagnosed between 2000 and 2009, matching each with four controls for age, sex and practice.

Regular statin use cut the odds of developing oesophageal adenocarcinoma by 42%, while high-dose statin use cut oesophagogastric junctional adenocarcinoma risk by 71%, the authors from the University of East Anglia found.

Statin use